| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,099 |
1,080 |
$63K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
719 |
609 |
$23K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
1,023 |
1,020 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
175 |
173 |
$9K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
235 |
233 |
$7K |
| 96127 |
|
424 |
424 |
$4K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
38 |
38 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
31 |
31 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
215 |
208 |
$2K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
13 |
13 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
44 |
44 |
$899.80 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
25 |
25 |
$787.53 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
61 |
60 |
$720.41 |
| 99051 |
|
44 |
44 |
$712.08 |
| 87081 |
|
40 |
39 |
$273.60 |
| 94760 |
|
30 |
30 |
$75.90 |